Youth-Nominated Support Team Intervention for Suicidal Adolescents

NCT ID: NCT00071617

Last Updated: 2013-11-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

448 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-11-30

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will attempt to improve treatment adherence and reduce suicide risk among adolescents who are at risk for attempting suicide.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Despite substantial knowledge about adolescent suicide risk factors, few studies have been conducted to identify effective interventions for suicidal adolescents.

Youth-Nominated Support Team (YST) is an intervention designed to help suicidal adolescents after hospitalization. It is a psychoeducational social network intervention that targets poor treatment adherence and difficulties with social support. YST is designed to be a supplement to traditional or usual treatments.

Participants are randomly assigned to receive either treatment as usual (TAU) or TAU plus YST for 3 months. Adolescents who receive TAU plus YST nominate three or four adults from their family, school, and community settings to function as support persons. The support persons participate in a psychoeducation session that focuses on the adolescent's psychiatric disorder(s), individualized treatment plan, importance of treatment adherence, and suicide risk factors. They also maintain regular contact with the adolescent to support treatment adherence and progress toward treatment goals. Adolescents have assessments at 6 weeks, 3 months, 6 months, and 12 months. Internalizing behavior problems, perceived social support, treatment adherence, adaptive functioning, severity of depression and anxiety, severity and frequency of suicidal thoughts, and suicide attempts are assessed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Suicide, Attempted

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Suicide Adolescence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Youth-Nominated Support Team

Adolescents nominate up to 4 caring adults from family, school, community settings. These adults participate in psychoeducation sessions regarding adolescent's treatment plan and support needs. They maintain regular, supportive contact with the adolescent for 3 months -- with ongoing consultation and support check-ins from study clinical staff.

Group Type EXPERIMENTAL

Youth-Nominated Support Team

Intervention Type BEHAVIORAL

Enhanced Treatment as Usual

Adolescents in this condition receive study assessments and risk management services (at time of assessments) only

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Youth-Nominated Support Team

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hospitalization in a participating psychiatric facility
* Suicidal ideation, intent, or attempt

Exclusion Criteria

* Severe physical or cognitive impairment that makes informed consent, nominations, or participation in assessments impossible
Minimum Eligible Age

13 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

University of Michigan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cheryl A. King

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cheryl A. King, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of Michigan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Child and Adolescent Psychiatry Hospital, University of Michigan

Ann Arbor, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Interventions for self-harm in children and adolescents. Cochrane Database Syst Rev. 2021 Mar 7;3(3):CD013667. doi: 10.1002/14651858.CD013667.pub2.

Reference Type DERIVED
PMID: 33677832 (View on PubMed)

King CA, Arango A, Kramer A, Busby D, Czyz E, Foster CE, Gillespie BW; YST Study Team. Association of the Youth-Nominated Support Team Intervention for Suicidal Adolescents With 11- to 14-Year Mortality Outcomes: Secondary Analysis of a Randomized Clinical Trial. JAMA Psychiatry. 2019 May 1;76(5):492-498. doi: 10.1001/jamapsychiatry.2018.4358.

Reference Type DERIVED
PMID: 30725077 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01MH063881

Identifier Type: NIH

Identifier Source: secondary_id

View Link

DSIR 84-CTS

Identifier Type: -

Identifier Source: secondary_id

R01MH063881

Identifier Type: NIH

Identifier Source: org_study_id

View Link